These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24846486)

  • 1. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison.
    Sendziuk P
    Can Bull Med Hist; 2007; 24(1):113-29. PubMed ID: 17644934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
    Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
    Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Dead-Space Syringes for HIV prevention among people who inject drugs: interesting, but a much stronger case is required.
    Ambekar A; Pawar A
    Int J Drug Policy; 2013 Jan; 24(1):16-8. PubMed ID: 23127665
    [No Abstract]   [Full Text] [Related]  

  • 6. Syringe exchanges: a public health response to problem drug use.
    Cox GM; Lawless MC; Cassin SP; Geoghegan TW
    Ir Med J; 2000; 93(5):143-6. PubMed ID: 11072923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to sterile syringes for injecting drug users in New York City: politics and perception (1984-2010).
    Heller D; Paone D
    Subst Use Misuse; 2011; 46(2-3):140-9. PubMed ID: 21303234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries.
    Zule WA; Cross HE; Stover J; Pretorius C
    Int J Drug Policy; 2013 Jan; 24(1):1-7. PubMed ID: 22884539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
    Newland J; Newman C; Treloar C
    Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clean switch: the case for prison needle and syringe programs.
    Chu S
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):5-19. PubMed ID: 20225504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
    Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
    Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More free syringes, fewer drug injectors in the case of Spain.
    Bravo MJ; Royuela L; Barrio G; de la Fuente L; Suarez M; Teresa Brugal M
    Soc Sci Med; 2007 Oct; 65(8):1773-8. PubMed ID: 17658207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of harm reduction service provision for people who inject drugs.
    O'Keefe D; Bluthenthal RN; Kral AH; Aitken CK; McCormack A; Dietze PM
    Bull World Health Organ; 2019 Sep; 97(9):605-611. PubMed ID: 31474773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of harm reduction in preventing HIV among injecting drug users.
    Wodak A; Maher L
    N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.